Several leading companies worldwide focus on the synthesis of complex pharmaceutical APIs, notably Abacavir Sulfate sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant difficulties in process development due to their molecular sophistication. The suppliers of these APIs often employ sophisticated processes and adhere t